1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
3
|
de Ruijter TC, Veeck J, de Hoon JP, van
Engeland M and Tjan-Heijnen VC: Characteristics of triple-negative
breast cancer. J Cancer Res Clin Oncol. 137:183–192. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Tomao F, Papa A, Zaccarelli E, Rossi L,
Caruso D, Minozzi M, Vici P, Frati L and Tomao S: Triple-negative
breast cancer: New perspectives for targeted therapies. Onco
Targets Ther. 8:177–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rota LM and Wood TL: Crosstalk of the
insulin-like growth factor receptor with the Wnt signaling pathway
in breast cancer. Front Endocrinol (Lausanne). 6:922015.PubMed/NCBI
|
6
|
Voduc KD, Cheang MC, Tyldesley S, Gelmon
K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk
of local and regional relapse. J Clin Oncol. 28:1684–1691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Bandyopadhyay S and Ali-Fehmi R: Breast
carcinoma: Molecular profiling and updates. Clin Lab Med.
33:891–909. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Polyak K: Heterogeneity in breast cancer.
J Clin Invest. 121:3786–3788. 2011. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Jeong H, Ryu YJ, An J, Lee Y and Kim A:
Epithelial-mesenchymal transition in breast cancer correlates with
high histological grade and triple-negative phenotype.
Histopathology. 60:E87–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Dong C, Wu Y, Yao J, Wang Y, Yu Y,
Rychahou PG, Evers BM and Zhou BP: G9a interacts with Snail and is
critical for Snail-mediated E-cadherin repression in human breast
cancer. J Clin Invest. 122:1469–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu S, Ye D, Guo W, Yu W, He Y, Hu J, Wang
Y, Zhang L, Liao Y, Song H, et al: G9a is essential for
EMT-mediated metastasis and maintenance of cancer stem cell-like
characters in head and neck squamous cell carcinoma. Oncotarget.
6:6887–6901. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Vedadi M, Barsyte-Lovejoy D, Liu F,
Rival-Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA,
Wasney GA, Siarheyeva A, et al: A chemical probe selectively
inhibits G9a and GLP methyltransferase activity in cells. Nat Chem
Biol. 7:566–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dong C, Yuan T, Wu Y, Wang Y, Fan TW,
Miriyala S, Lin Y, Yao J, Shi J, Kang T, et al: Loss of FBP1 by
Snail-mediated repression provides metabolic advantages in
basal-like breast cancer. Cancer Cell. 23:316–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rakha EA and Chan S: Metastatic
triple-negative breast cancer. Clin Oncol (R Coll Radiol).
23:587–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kumar P and Aggarwal R: An overview of
triple-negative breast cancer. Arch Gynecol Obstet. 293:247–269.
2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lin Y, Dong C and Zhou BP: Epigenetic
regulation of EMT: The Snail story. Curr Pharm Des. 20:1698–1705.
2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hsiao SM, Chen MW, Chen CA, Chien MH, Hua
KT, Hsiao M, Kuo ML and Wei LH: The H3K9 Methyltransferase G9a
Represses E-cadherin and is associated with myometrial invasion in
endometrial cancer. Ann Surg Oncol. 22 Suppl 3:S1556–S1565. 2015.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Luo M, Brooks M and Wicha MS:
Epithelial-mesenchymal plasticity of breast cancer stem cells:
Implications for metastasis and therapeutic resistance. Curr Pharm
Des. 21:1301–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wu Y, Sarkissyan M and Vadgama JV:
Epithelial-mesenchymal transition and breast cancer. J Clin Med.
5:pii: E132016. View Article : Google Scholar
|
25
|
Fillmore CM and Kuperwasser C: Human
breast cancer cell lines contain stem-like cells that self-renew,
give rise to phenotypically diverse progeny and survive
chemotherapy. Breast Cancer Res. 10:R252008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Singh JK, Farnie G, Bundred NJ, Simões BM,
Shergill A, Landberg G, Howell SJ and Clarke RB: Targeting CXCR1/2
significantly reduces breast cancer stem cell activity and
increases the efficacy of inhibiting HER2 via HER2-dependent and
-independent mechanisms. Clin Cancer Res. 19:643–656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Hwang-Verslues WW, Kuo WH, Chang PH, Pan
CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al:
Multiple lineages of human breast cancer stem/progenitor cells
identified by profiling with stem cell markers. PLoS One.
4:e83772009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Horibata S, Vo TV, Subramanian V, Thompson
PR and Coonrod SA: Utilization of the soft agar colony formation
assay to identify inhibitors of tumorigenicity in breast cancer
cells. J Vis Exp. e527272015.PubMed/NCBI
|
29
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|